Ninth Circuit Intellectual Property Cases

Patent - Abbreviated New Drug Application Cases, Dockets and Filings
Cases filed
Cases 1 - 8 of 8
Bristol-Myers Squibb Company v. Handa Oncology, LLC We have downloadable decisions or orders for this case
as 3:2022cv06968
Plaintiff: Bristol-Myers Squibb Company
Defendant: Handa Oncology, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Handa Neuroscience, LLC et al We have downloadable decisions or orders for this case
as 5:2021cv03397
Defendant: Handa Pharmaceuticals, LLC, Handa Neuroscience, LLC, Handa Pharma, Inc. and others
Plaintiff: Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 145
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc. et al
as 3:2020cv00421
Defendant: Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.
Plaintiff: Amarin Pharmaceuticals Ireland Limited and Amarin Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271
Alkermes Pharma Ireland Limited et al v. Luye Pharma Group LTD. et al
as 3:2019cv02227
Plaintiff: Alkermes Pharma Ireland Limited, Alkermes Controlled Therapeutics, Inc. and Janssen Pharmaceuticals, Inc.
Defendant: Luye Pharma (USA) LTD., Luye Pharma Group LTD., Nanjing Luye Pharmaceutical Co., LTD. and others
Petitioner: Ajinomoto Althea, Inc.
Cause Of Action: 35 U.S.C. § 0271
Keryx Biopharmaceuticals, Inc. et al v. Watson Laboratories, Inc. et al
as 2:2019cv00837
Plaintiff: Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc.
Defendant: Watson Laboratories, Inc., Teva Pharmaceutical Industries Limited and Teva Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 145
Uniloc USA, Inc. et al v. Apple Inc.
as 3:2019cv01694
Defendant: Apple Inc
Plaintiff: UNILOC Luxembourg S.A. and Uniloc USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Amarin Pharma, Inc. et al v. Dr. Reddy's Laboratories, Inc. et al
as 2:2018cv01596
Defendant: Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Plaintiff: Amarin Pharmaceuticals Ireland Limited and Amarin Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271
Fresenius Kabi USA, LLC v. BioQ Pharma Incorporated
as 3:2018cv01408
Plaintiff: Fresenius Kabi USA, LLC
Defendant: BioQ Pharma Incorporated
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?